Agency Information Collection Activities: Proposed Collection; Comment Request; Bar Code Label Requirement for Human Drug and Biological Products; Correction, 79912 [2015-32252]
Download as PDF
79912
Federal Register / Vol. 80, No. 246 / Wednesday, December 23, 2015 / Notices
TABLE 2—ESTIMATED ANNUAL REPORTING BURDEN 1—Continued
Number of
respondents
Activity
Number of responses per
respondent
Total annual
responses
Average burden per
response
Total hours
Pretest ..........................................................................
Main Study Screener ...................................................
Main Study ...................................................................
640
2,112
1,056
1
1
1
640
2,112
1,056
0.75 (45 minutes)
0.08 (5 minutes)
0.75 (45 minutes)
480
169
792
Total ......................................................................
5,193
1
5,193
................................
1,560
1 There
are no capital costs or operating and maintenance costs associated with the collection of information.
tkelley on DSK3SPTVN1PROD with NOTICES
V. References
The following references are on
display in the Division of Dockets
Management (HFA–305), Food and Drug
Administration, 5630 Fishers Lane, Rm.
1061, Rockville, MD 20852, and are
available for viewing by interested
persons between 9 a.m. and 4 p.m.,
Monday through Friday; they are also
available electronically at https://
www.regulations.gov. FDA has verified
the Web site addresses, as of the date
this document publishes in the Federal
Register, but Web sites are subject to
change over time.
1. Zhong W., H. Maradit-Kremers, J.L. St.
Sauver, et al., ‘‘Age and Sex Patterns of
Drug Prescribing in a Defined American
Population.’’ Mayo Clinic Proceedings.
88(7):697–707, 2013.
2. Depp C.A., D.A. Schkade, W.K. Thompson,
D.V. Jeste. ‘‘Age, Affective Experience,
and Television Use.’’ American Journal
of Preventative Medicine. 39:173–8,
2010.
3. Agrawal Y., E.A. Platz, J.K. Niparko.
‘‘Prevalence of Hearing Loss and
Differences by Demographic
Characteristics Among US Adults.’’
Archives of Internal Medicine.
168(14):1522–30, 2008.
4. Cruickshanks K.J., T.L. Wiley, T.S. Tweed,
et al., ‘‘Prevalence of Hearing Loss in
Older Adults in Beaver Dam,
Wisconsin.’’ American Journal of
Epidemiology. 148(9):879–86, 1998.
5. Lin FR, R. Thorpe, S. Gordon-Salant, L.
Ferrucci. ‘‘Hearing Loss Prevalence and
Risk Factors Among Older Adults in the
United States.’’ The Journals of
Gerontology Series A: Biological
Sciences and Medical Sciences.
66A(5):582–90, 2011.
6. Garstecki DC, S.F. Erler. ‘‘Hearing Loss,
Control, and Demographic Factors
Influencing Hearing Aid Use Among
Older Adults.’’ Journal of Speech,
Language, and Hearing Research.
41:527–37, 1998.
7. Gates G.A., J.C. Cooper. ‘‘Incidence of
Hearing Decline in the Elderly.’’ Acta
Oto-laryngol. 111:240–8, 1991.
8. Humes L.E. ‘‘Speech Understanding in the
Elderly.’’ Journal of the American
Academy of Audiology. 7:161–7, 1996.
9. U.S. Food and Drug Administration. Code
of Federal Regulations. Prescription drug
advertisements, 21 CFR Sect. 202.1.
2013. (https://www.accessdata.fda.gov/
scripts/cdrh/cfdocs/cfCFR/
VerDate Sep<11>2014
18:05 Dec 22, 2015
Jkt 238001
CFRSearch.cfm?fr=202.1)
10. Wingfield A., L.W. Poon, L. Lombardi, D.
Lowe. ‘‘Speed of Processing in Normal
Aging: Effects of Speech Rate, Linguistic
Structure, and Processing Time.’’ The
Journals of Gerontology. 40(5):579–85,
1985.
11. Kramer A.F., S. Hahn, D. Gopher. ‘‘Task
Coordination and Aging: Explorations of
Executive Control Processes in the Task
Switching Paradigm.’’ Acta
Psychologica. 101:339–78, 1999.
12. Naveh-Benjamin M., J. Guez, A. Kilb, S.
Reedy. ‘‘The Associative Memory Deficit
of Older Adults: Further Support Using
Face-Name Associations.’’ Psychology
and Aging. 19(3):541–6, 2004.
13. Sommers M.S., N. Tye-Murray, B. Spehar.
‘‘Auditory-Visual Speech Perception and
Auditory-Visual Enhancement in
Normal-Hearing Younger and Older
Adults.’’ Ear and Hearing. 26(3):263–75,
2005.
14. Watson J.M., K.B. McDermott, D.A.
Balota. ‘‘Attempting to Avoid False
Memories in the Deese/RoedigerMcDermott Paradigm: Assessing the
Combined Influence of Practice and
Warnings in Young and Old Adults.’’
Memory and Cognition. 32(1):135–41,
2004.
15. Gates G.A., M.P. Feeney, D. Mills. ‘‘CrossSectional Age-Changes of Hearing in the
Elderly.’’ Ear and Hearing. 29(6):865–74,
2008.
16. Morrell C.H., S. Gordon-Salant, J.D.
Pearson, L.J. Brant, J.L. Fozard. ‘‘Ageand Gender-Specific Reference Ranges
for Hearing Level and Longitudinal
Changes in Hearing Level.’’ Journal of
the Acoustical Society of America.
100(4)Pt. 1:1949–67, 1996.
17. Cutler A., D. Dahan, W. van Donselaar.
‘‘Prosody in the Comprehension of
Spoken Language: A Literature Review.’’
Language and Speech. 40(2):141–201,
1997.
Dated: December 15, 2015.
Leslie Kux,
Associate Commissioner for Policy.
[FR Doc. 2015–32251 Filed 12–22–15; 8:45 am]
BILLING CODE 4164–01–P
PO 00000
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2012–N–0873]
Agency Information Collection
Activities: Proposed Collection;
Comment Request; Bar Code Label
Requirement for Human Drug and
Biological Products; Correction
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice; correction.
The Food and Drug
Administration (FDA) is correcting a
notice entitled ‘‘Agency Information
Collection Activities: Proposed
Collection; Comment Request; Bar Code
Label Requirement for Human Drug and
Biological Products’’ that appeared in
the Federal Register of December 15,
2015 (80 FR 77637). The document
solicited comments on the bar code
label requirements for human drug and
biological products. The document was
published with an incorrect docket
number. This document corrects that
error.
SUMMARY:
Lisa
Granger, Office of Policy and Planning,
Food and Drug Administration, 10903
New Hampshire Ave., Bldg. 32, rm.
3330, Silver Spring, MD 20993–0002,
301–796–9115.
FOR FURTHER INFORMATION CONTACT:
In the
Federal Register of Tuesday, December
15, 2015, in FR Doc. 2015–31402, the
following correction is made:
1. On page 77637, in the second
column, the docket number is corrected
to read FDA–2012–N–0873.
SUPPLEMENTARY INFORMATION:
Dated: December 15, 2015.
Leslie Kux,
Associate Commissioner for Policy.
[FR Doc. 2015–32252 Filed 12–22–15; 8:45 am]
BILLING CODE 4164–01–P
Frm 00096
Fmt 4703
Sfmt 9990
E:\FR\FM\23DEN1.SGM
23DEN1
Agencies
[Federal Register Volume 80, Number 246 (Wednesday, December 23, 2015)]
[Notices]
[Page 79912]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-32252]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA-2012-N-0873]
Agency Information Collection Activities: Proposed Collection;
Comment Request; Bar Code Label Requirement for Human Drug and
Biological Products; Correction
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice; correction.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA) is correcting a notice
entitled ``Agency Information Collection Activities: Proposed
Collection; Comment Request; Bar Code Label Requirement for Human Drug
and Biological Products'' that appeared in the Federal Register of
December 15, 2015 (80 FR 77637). The document solicited comments on the
bar code label requirements for human drug and biological products. The
document was published with an incorrect docket number. This document
corrects that error.
FOR FURTHER INFORMATION CONTACT: Lisa Granger, Office of Policy and
Planning, Food and Drug Administration, 10903 New Hampshire Ave., Bldg.
32, rm. 3330, Silver Spring, MD 20993-0002, 301-796-9115.
SUPPLEMENTARY INFORMATION: In the Federal Register of Tuesday, December
15, 2015, in FR Doc. 2015-31402, the following correction is made:
1. On page 77637, in the second column, the docket number is
corrected to read FDA-2012-N-0873.
Dated: December 15, 2015.
Leslie Kux,
Associate Commissioner for Policy.
[FR Doc. 2015-32252 Filed 12-22-15; 8:45 am]
BILLING CODE 4164-01-P